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Abstract. 
 
The eukaryotic initiation factor 4E (eIF4E) 
plays a pivotal role in the control of protein synthesis. 
 
eIF4E binds to the mRNA 5
 
9
 
 cap structure, m
 
7
 
GpppN 
(where N is any nucleotide) and promotes ribosome 
binding to the mRNA. It was previously shown that a 
fraction of eIF4E localizes to the nucleus (Lejbkowicz, 
F., C. Goyer, A. Darveau, S. Neron, R. Lemieux, and
N. Sonenberg. 1992. 
 
Proc. Natl. Acad. Sci. USA.
 
 89:
9612–9616). Here, we show that the nuclear eIF4E is 
present throughout the nucleoplasm, but is concen-
trated in speckled regions. Double label immunoﬂuo-
rescence confocal microscopy shows that eIF4E colo-
calizes with Sm and U1snRNP. We also demonstrate 
that eIF4E is speciﬁcally released from the speckles by 
the cap analogue m
 
7
 
GpppG in a cell permeabilization 
assay. However, eIF4E is not released from the speck-
les by RNase A treatment, suggesting that retention
of eIF4E in the speckles is not RNA-mediated. 5,6-
 
dichloro-1-
 
b
 
-
 
D
 
-ribofuranosylbenzimidazole (DRB) 
treatment of cells causes the condensation of eIF4E
nuclear speckles. In addition, overexpression of the 
dual speciﬁcity kinase, Clk/Sty, but not of the catalyti-
cally inactive form, results in the dispersion of eIF4E 
nuclear speckles.
Key words: nuclear proteins • peptide initiation fac-
tor • RNA caps • RNA splicing • cap-binding protein
 
Introduction
 
In eukaryotes, all RNA polymerase II transcripts acquire
cotranscriptionally the 5
 
9
 
-terminal structure, m
 
7
 
G(5
 
9
 
)ppp-
(5
 
9
 
)N termed cap (Salditt-Georgieff et al., 1980). The cap
consists of a 7-methyl-guanosine residue, linked via a 5
 
9
 
–5
 
9
 
triphosphate bridge to the first transcribed nucleotide
(Shatkin, 1976). The cap is involved in numerous aspects
of mRNA metabolism, including RNA stability (Furuichi
et al., 1977; Shimotohno et al., 1977; Murthy et al., 1991),
3
 
9 
 
end mRNA processing (Hart et al., 1985), pre-mRNA
splicing (Konarska et al., 1984; Edery and Sonenberg,
1985), nuclear export (Hamm and Mattaj, 1990; Jar-
molowski et al., 1994), and translation initiation (Shat-
kin, 1985). Mammalian eukaryotic initiation factor 4E
 
(eIF4E)
 
1
 
 is a 24-kD cap-binding protein (Sonenberg et
al., 1978, 1979) that can be purified as a monomer or as a
subunit in a complex called eIF4F. eIF4F is a heterotri-
meric complex composed of eIF4E, eIF4A, and eIF4G.
eIF4A is an ATP-dependent RNA helicase and eIF4G is a
modular scaffolding protein that binds to both eIF4E and
eIF4A and other proteins (Imataka and Sonenberg, 1997;
for review see Gingras et al., 1999). eIF4E plays an impor-
tant role in the control of gene expression. It is the limiting
factor for translation initiation (Duncan et al., 1987) and
its overexpression in NIH3T3 cells causes malignant trans-
formation (Lazaris-Karatzas et al., 1990). Conversely, in
vivo depletion of eIF4E by antisense RNA partially re-
verses the transformed phenotype of 
 
ras
 
-overexpressing
cells (Rinker-Schaeffer et al., 1993).
Nuclear cap-binding proteins that are likely to mediate
the various nuclear functions of the cap have been detected
and some identified (Patzelt et al., 1983; Rozen and Sonen-
berg, 1987; Izaurralde et al., 1992). For example, the nu-
clear cap-binding complex (CBC), composed of CBP20 and
CBP80, is involved in mRNA splicing (Izaurralde et al.,
1994; Lewis et al., 1996). CBC also stimulates nucleocyto-
plasmic export of UsnRNAs (Izaurralde et al., 1995). A
 
study on the Balbiani ring mRNA export of 
 
Chironomus
tentans
 
 demonstrates that CBC binds cotranscriptionally to
the cap and accompanies the ribonucleoprotein particle
during nuclear export (Visa et al., 1996). Additionally, CBC
 
stimulates mRNA 3
 
9 
 
end processing (Flaherty et al., 1997).
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Abbreviations used in this paper:
 
 CBC, cap-binding complex; DRB,
 
5,6-dichloro-1-
 
b
 
-
 
D
 
-ribofuranosylbenzimidazole; eIF4E, eukaryotic initia-
tion factor 4E; RT, room temperature. 
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Cellular fractionation and immunofluorescence analysis
demonstrated that a sizeable fraction (12–33%) of total
eIF4E is localized to the nucleus of mammalian cells
(Lejbkowicz et al., 1992). Electron microscope studies
showed that eIF4E is also present in the nucleus of
 
 Sac-
charomyces cerevisiae 
 
(Lang et al., 1994). These results
raise the possibility that eIF4E may also play a nuclear
role in mRNA metabolism, such as splicing or transport.
Many, but not all, splicing factors are concentrated in sub-
nuclear structures termed “speckles”. The speckles (20–50
speckles per nucleus) are irregular shaped bodies. Al-
though the precise function of the speckles remains con-
troversial, there is evidence that the speckles are sites of
posttranscriptional splicing (Xing et al., 1993, 1995) and of
splicing component storage and/or assembly (Puvion and
Puvion-Dutilleul, 1996; Spector, 1996). Here, we show that
the nuclear fraction of eIF4E colocalizes with splicing fac-
tors in the speckles. We demonstrate that the nuclear dis-
tribution of eIF4E is sensitive to RNA polymerase II tran-
scription inhibitors and the availability of cap structures,
but not to RNase treatment. Similar to serine/arginine-rich
(SR) splicing factors, the localization of eIF4E is regulated
by the dual specificity kinase, Clk/Sty.
 
Materials and Methods
 
Plasmids and Antibodies
 
Plasmids encoding myc-Clk/Sty 
 
wt
 
 and myc-Clk/Sty
 
K190R
 
 (Colwill et al.,
1996) and rabbit anti-myc antibody (A-14) were kindly provided by J.C.
Bell (University of Ottawa, Ottawa, Canada). Human anti-Sm sera and
human anti-U1snRNP sera were provided by the Center for Disease Con-
trol (Atlanta, GA). mAb SC35 was a kind gift from X.D. Fu and T. Mani-
atis (Harvard University, Cambridge, MA). 10C6 is an anti-mouse eIF4E
mAb (Lejbkowicz et al., 1992). Texas red- and fluorescein-conjugated sec-
ondary antibodies were purchased from Molecular Probes, Inc.
 
Immunofluorescence Assay
 
CV-1 monkey kidney cells and HeLa cells were plated at 2 
 
3
 
 10
 
4
 
 per
chamber on Lab-Tek chamber slides (Nunc) and grown to subconfluence
in DME supplemented with 10% FBS. Cells were fixed for 1 h with 4%
formaldehyde in PBS and permeabilized for 1 h with 4% formaldehyde/
0.2% Tween 20 in PBS at room temperature (RT). Cells were briefly re-
hydrated with 0.2% Tween 20 in PBS before blocking overnight in a solu-
tion containing 50% FBS, 6% skim milk, 3% BSA, 0.2% Tween 20, and
0.02% sodium azide. Cells were incubated with primary antibodies for 2 h
at RT or overnight at 4
 
8
 
C, and washed extensively with 0.2% Tween 20/
PBS before and after incubation with secondary antibodies for 30 min to 1 h
at RT. Cells were mounted in 30% glycerol in PBS and analyzed by confo-
cal microscopy. For incubation of HeLa cells with drugs, cycloheximide
was added at a final concentration of 20 
 
m
 
M and 5,6-dichloro-1-
 
b
 
-
 
D
 
-ribo-
furanosylbenzimidazole (DRB) was used at 100 
 
m
 
M.
 
Cell Permeabilization Assay
 
The assay was done as described previously, except for a few modifica-
tions (Adam et al., 1990). In brief, HeLa cells were plated at low density
on coverslips, grown in DME/10%FBS for at least 24 h, and the media was
changed 2–4 h before the experiment. Coverslips were briefly rinsed in
transport buffer (20 mM Hepes/KOH, pH 7.3, 110 mM potassium acetate,
2 mM sodium acetate, 5 mM magnesium acetate, 1 mM EGTA, 2 mM
ditriothreitol, 1 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pepstatin) and
incubated for 4 min at RT in transport buffer containing 40 
 
m
 
g/ml digito-
nin. Coverslips were gently rinsed and inverted on a parafilm sheet over a
drop of transport buffer containing 2 
 
m
 
g/
 
m
 
l BSA and 50 mM m
 
7
 
GpppG or
GpppG. The reaction was done at 30
 
8
 
C for 25 min. Cells were rinsed,
fixed in transport buffer containing 3% formaldehyde, and processed for
immunofluorescence as described above. This experiment was performed
three times with the same results.
 
RNase Digestion
 
RNase treatment was performed as previously described (Spector et al.,
1991). In brief, cells (CV-1) were fixed in methanol for 2 min at 
 
2
 
20
 
8
 
C,
rinsed in PBS, and incubated with RNase A (100 
 
m
 
g/ml) for 2 h at RT.
Cells were washed several times and processed for immunofluorescence
as described.
 
Transient Transfections
 
HeLa cells were plated at low density on 60-mm dishes in DME/10% FBS.
At 50% confluency, cells were transfected with 10 
 
m
 
g of plasmid DNA by
the calcium phosphate transfection method (Graham and Eb, 1973). Cells
were fixed and processed for immunofluorescence 24 h after transfection.
 
Results
 
Nuclear eIF4E Colocalizes with Splicing Factors
 
An mAb (10C6) that recognizes eIF4E in the nucleus
(Lejbkowicz et al., 1992) was used for immunostaining of
HeLa cells. The immunofluorescence shows that nuclear
eIF4E is excluded from the nucleoli and concentrated in
speckles that are characteristic of those observed to con-
tain splicing factors (Fig. 1). To determine whether eIF4E
colocalizes with splicing factors, antibodies against three
different components of the splicing machinery were used:
anti-SC35 (an SR protein; Fu and Maniatis, 1990); anti-
Sm; and anti-U1snRNP. To ascertain that incubation with
the three antibodies results in the characteristic nuclear
pattern reported earlier, double label immunofluores-
cence was performed (Lerner et al., 1981; Fu and Maniatis,
1990). Staining with anti-SC35 (Fig. 2 A, a and d), anti-Sm
(Fig. 2 A, b), and anti-U1snRNP (Fig. 2 A, e) shows a typ-
ical speckled pattern. In addition, SC35 colocalizes with
Sm (Fig. 2 A, c) and U1snRNP (Fig. 2 A, f), as visualized
in the merged pictures and as previously described (Fu
and Maniatis, 1990).
To examine whether eIF4E colocalizes with Sm and
U1snRNP, cells were incubated with anti-eIF4E (Fig. 2 B,
a and d), anti-Sm (Fig. 2 B, b), or anti-U1snRNP (Fig. 2 B,
e). The merged images show that eIF4E colocalizes with
Sm and U1snRNP (Fig. 2 B, c and f). It is thought that the
speckles represent storage and/or assembly sites for many
splicing and transcription components (Bregman et al.,
1995; Spector, 1996), as well as splicing sites (Xing et al.,
1993, 1995). Consequently, eIF4E might be involved in nu-
clear mRNA processing.
 
The Nuclear Distribution of eIF4E Is Sensitive to RNA 
Polymerase II Transcription
 
Inhibition of RNA polymerase II transcription by the nu-
cleoside DRB was shown to cause the rounding up of
splicing factor speckles (Spector et al., 1993). To deter-
mine whether the localization of nuclear eIF4E is also sen-
sitive to RNA pol II transcription inhibition, HeLa cells
were treated with DRB alone or in the presence of cyclo-
heximide to inhibit protein synthesis. Addition of DRB in
the presence or absence of cycloheximide resulted in the
rounding up of eIF4E (Fig. 3, c and d), SC35 (Fig. 3, g and
h), and Sm (Fig. 3, k and l) speckles. Similar results were 
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also obtained when cells were treated with 
 
a
 
-amanitin
(data not shown). Incubation with cycloheximide alone
had no effect on the distribution of either protein (Fig. 3,
b, f, and g). These results show that similar to splicing com-
ponents, the nuclear distribution of eIF4E is sensitive to
RNA pol II transcription and is independent of transla-
tion.
 
eIF4E Is Released from the Nucleus by the 
Monomethylated Cap Analogue, but Not by
RNase Treatment
 
Because eIF4E mediates the mRNA cap structure func-
tion during translation initiation, it was of interest to de-
termine the effect of cap analogues on eIF4E localization.
HeLa cells were permeabilized with digitonin, rinsed to re-
move soluble proteins, and incubated with m
 
7
 
GpppG or
GpppG. Following treatment, cells were rinsed to wash
away proteins that were released from the nucleus upon
treatment. Incubation with buffer alone did not alter the
speckled pattern of eIF4E or SC35 (Fig. 4 A, left; com-
pare with Fig. 2 A). However, incubation of cells with
m
 
7
 
GpppG specifically released eIF4E from the nucleus
(Fig. 4 A, middle), whereas GpppG had no significant ef-
fect (Fig. 4 A, right). The signal intensity for SC35 was not
significantly changed by m
 
7
 
GpppG or GpppG. These re-
sults might suggest that the nuclear eIF4E is associated
with the cap structure of mRNAs in the speckles. Alterna-
tively, it is possible that eIF4E in the speckles is not RNA-
bound, but is released from the speckles as a consequence
of its interaction with the vast excess of exogenous cap an-
alogue in the nucleoplasm, which competes for the binding
of eIF4E with speckled elements.
One of the elements in the speckles that binds eIF4E
could be capped RNA. To determine whether eIF4E is re-
tained in the nucleus in an RNA-dependent manner, CV-1
cells were treated with RNase A and the localization of
eIF4E was examined by immunofluorescence (Fig. 4 B).
RNase A treatment had no effect on the localization of
eIF4E (Fig. 4 B, a and d). As previously reported, the
Sm (Fig. 4 B, c and f), but not SC35 (Fig. 4 B, b and e), dis-
tribution is dramatically changed after this treatment
Figure 1. Nuclear eIF4E localizes to speckles. The localization of
endogenous eIF4E was determined by indirect immunofluores-
cence with a monoclonal anti-mouse eIF4E antibody, 10C6, and
Texas red-conjugated secondary antibody. HeLa cells were fixed
and processed for immunofluorescence as described in Materials
and Methods. Images were taken from a 633 objective of a Zeiss
LSM 410 microscope and analyzed with a Kontron IBAS confo-
cal imaging system. Bar, 10 mm.
Figure 2. eIF4E colocalizes with Sm and U1snRNP antigens to
speckled regions in the nucleus. A, a–c, SC35 colocalizes with
Sm. The localization of endogenous SC35 was determined by in-
direct immunofluorescence with a monoclonal anti-mouse SC35
antibody and Texas red-conjugated anti-mouse IgG (a and c),
and that of Sm with a human anti-Sm sera and fluorescein-conju-
gated anti-human IgG (b and c). d–f, SC35 colocalizes with
U1snRNP. Same as in a–c, except that a human anti-U1snRNP
sera was used in e and f. Bar, 5 mm. B, a–c, eIF4E colocalizes with
Sm. The localization of eIF4E was determined by indirect immu-
nofluorescence with the monoclonal anti-mouse eIF4E antibody
10C6 and Texas red-conjugated anti-mouse IgG (a and c), and
that of Sm with a human anti-Sm sera and fluorescein-conjugated
anti-human IgG (b and c). d–f, Same as in a–c, except that a hu-
man anti-U1snRNP sera was used in e and f. Bar, 10 mm. In c and
f (in both A and B), the colocalization appears yellow. CV-1
monkey kidney cells were prepared as described in Materials and
Methods. Images were taken from a 633 objective of a BioRad
MRC-600 confocal imaging system mounted on a Nikon Dia-
phot-TMD microscope as previously described (Lejbkowicz et al.,
1992).  
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whereby it becomes diffuse in the nucleoplasm (Spector
et al., 1992). These results suggest that the localization of
eIF4E in the speckles does not appear to require its associ-
ation with RNA. However, this negative result needs to be
interpreted with caution. RNase treatment might not be
expected to remove eIF4E from the speckles, if when
bound to RNA, eIF4E interacts with both RNA and other
insoluble proteins or structural elements in the speckles.
 
The Nuclear Distribution of eIF4E Is Regulated by the 
Dual Specificity Kinase Clk/Sty
 
Splicing factors of the SR family are substrates for the dual
specificity kinase, Clk/Sty (Colwill et al., 1996). Expression
of mammalian Clk/Sty 
 
wt
 
 in COS-1 cells causes the release
of SR proteins from the speckles, whereas a catalytically
inactive Clk/Sty does not (Colwill et al., 1996; Caceres et al.,
1998). To examine whether Clk/Sty also affects the local-
ization of eIF4E, HeLa cells were transiently transfected
with myc-Clk/Sty 
 
wt
 
 or the catalytically inactive myc-Clk/
Sty
 
K190R
 
, and the localization of eIF4E was determined by
immunofluorescence. Expression of Clk/Sty 
 
wt
 
, but not
Clk/Sty
 
K190R
 
, resulted in the disruption of the eIF4E speck-
les (Fig. 5, A and B, top). As previously reported, in trans-
fected cells using anti-SC35 or the anti-SR mAb 104,
which is specific for phosphorylated SR proteins and rec-
ognizes all SR family members (Colwill et al., 1996; Ca-
ceres et al., 1998), Clk/Sty 
 
wt
 
, but not the catalytically inac-
tive kinase, released the SR splicing factors from the
speckles (Fig. 5, A and B, middle and bottom; Colwill et
al., 1996). Taken together, these results indicate that the
nuclear localization of eIF4E is regulated by the dual spec-
ificity kinase, Clk/Sty.
 
Discussion
 
Nuclear eIF4E is shown here to be distributed throughout
the nucleoplasm, but is concentrated in speckles. Electron
microscope studies identified the splicing factor-enriched
speckles as clusters of interchromatin granules surrounded
by perichromatin fibrils (Spector, 1993). The fluorescence
from the speckles, as detected with antibodies against vari-
ous splicing factors, such as SC35, corresponds to in-
terchromatin granules and some perichromatin fibrils,
whereas the more dispersed nucleoplasmic signal repre-
sents perichromatin fibrils, which are mostly localized
throughout the nucleus (Spector, 1996). Although numer-
Figure 3. Effect of transcription inhibition on the localization of
eIF4E. HeLa cells were incubated with buffer alone (a, e, and i),
cycloheximide (b, f, and j), DRB (c, g, and k), or in the presence
of cycloheximide and DRB (d, h, and l) for 3 h. Cells were fixed
and the localization of eIF4E, SC35, and Sm was determined by
indirect immunofluorescence with the anti-eIF4E mAb 10C6
(top), anti-mouse SC35 mAb (middle), and with a human anti-
Sm antisera (bottom). Primary antibodies were detected with
Texas red-conjugated secondary antibodies and analyzed with a
Kontron IBAS confocal imaging system. Images were taken from
a 633 objective of a Zeiss LSM 410 microscope. Bar, 10 mm.
Figure 4. Nuclear eIF4E is released from the speckles by the
monomethylated cap structure, but not by RNase treatment. A,
HeLa cells were permeabilized with digitonin and incubated with
buffer alone (left), m7GpppG (middle), or GpppG (right) for 25
min. The cells were rinsed and fixed as described in Materials and
Methods. The localization of eIF4E (top) and SC35 (bottom) was
determined by indirect immunofluorescence with the anti-eIF4E
mAb 10C6 and monoclonal anti-SC35, respectively. Primary an-
tibodies were detected with Texas red-conjugated mouse second-
ary antibodies and analyzed with a Kontron IBAS confocal imag-
ing system. Images were taken from a 633 objective of a Zeiss
LSM 410 microscope. Bar, 10 mm. B, CV-1 cells were fixed with
methanol and incubated with PBS (a–c) or 100 mg/ml RNase A.
The localization of eIF4E (a and d), SC35 (b and e), and Sm (c
and f) was determined by indirect immunofluorescence with the
anti-eIF4E mAb 10C6, monoclonal anti-mouse SC35, and human
anti-Sm sera, respectively. Primary antibodies were detected with
Texas red-conjugated mouse secondary antibodies. Images were
taken from a 633 objective of a BioRad MRC-600 confocal im-
aging system mounted on a Nikon Diaphot-TMD microscope as
previously described (Lejbkowicz et al., 1992). Bar, 10 mm. 
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ous studies have provided abundant information about the
composition of the speckles, the precise function of these
structures remains unclear. One model suggests that the
speckles are splicing component storage sites, from which
they are recruited to nascent pre-mRNA transcription
sites (Singer and Green, 1997). This is consistent with the
observations that most pre-mRNAs are spliced cotran-
scriptionally (Beyer and Osheim, 1988; Spector, 1996; Slee-
man and Lamond, 1999), and that nascent RNA detected
by short pulses of [
 
3
 
H]uridine primarily localize to the peri-
chromatin fibrils and not to the interchromatin granules
(Spector, 1996). The detection by in situ hybridization of
several pre-mRNAs and corresponding spliced mRNAs
within the speckles suggests that some splicing may also
occur within these structures (Xing et al., 1993, 1995).
In a cell permeabilization assay, eIF4E was specifically
released from the nucleus by m
 
7
 
GpppG (Fig. 4 A). One in-
terpretation of this result could be that eIF4E is associated
with pre-mRNA in the speckles, and that this association
is disrupted by m
 
7
 
GpppG. This model is consistent with
previous electron microscope studies demonstrating that
the speckles contain poly A RNA (Carter et al., 1991). Al-
ternatively, it is possible that the speckled eIF4E is not as-
sociated with mRNA and that eIF4E in the speckles is re-
leased to the nucleoplasm as a result of its interaction with
the excess cap analogue. This is consistent with the resis-
tance of eIF4E in the speckles to RNase treatment. How-
ever, as indicated earlier, the resistance of eIF4E to RNase
treatment is not definitive proof for the lack of association
of eIF4E with mRNA. Taken together, our results sug-
gests that eIF4E is retained in the speckles primarily
through its association with proteins and not RNA.
The localization of eIF4E to the speckles raises the pos-
sibility of a role in mRNA processing. This is consistent
with the observation that DRB causes the clustering of
eIF4E speckles. DRB and 
 
a
 
-amanitin inhibit RNA poly-
merase II transcription at the elongation step (Cochet-
Meilhac and Chambon, 1974; Koumenis and Giaccia,
1997; Zhu et al., 1997) and cause the rounding up of splic-
ing factor speckles (Spector et al., 1993; Spector, 1996). It
was suggested that the clustering of splicing factors results
from the accumulation of splicing components at the stor-
age sites in response to the reduction of pre-mRNA levels
(Spector, 1996), and as a consequence, in less splicing.
Accordingly, disruption of pre-mRNA splicing in vivo
by microinjected oligonucleotides or antibodies against
snRNAs also causes the clustering of splicing factors
(O’Keefe et al., 1994). This explanation could also apply to
eIF4E as a potential component of the splicing machinery.
Since U1 and U2 snRNAs colocalize with snRNPs and
SC35 (Huang and Spector, 1992), eIF4E could, in princi-
ple, also be associated with the trimethylated cap (m3G)
of UsnRNAs in the speckles. However, this does not ap-
pear likely because UsnRNPs can be quantitatively immu-
noprecipitated from intact particles with an m3G-specific
antibody (Bringmann et al., 1983), indicating that this
structure is not sequestered by proteins (Kramer et al.,
1984). Also, the affinity of eIF4E for the trimethylated cap
structure is tenfold less than that for the monomethylated
cap (Wieczorek et al., 1999). Additionally, the m3G cap is
a poor inhibitor of cap-dependent translation and substitu-
tion of the monomethylated cap with the trimethylated
Figure 5. The nuclear localization of eIF4E is regulated by Clk/
Sty. HeLa cells were transiently transfected with myc-Clk/Sty
wild-type (A) or myc-Clk/StyK190R (B) for 24 h. The localization
of endogenous eIF4E and SC35, or SR splicing factors was deter-
mined with mAbs 10C6, anti-SC35, and anti-SR 104, respectively,
and revealed with Texas red-conjugated secondary antibody. The
distribution of transiently transfected Clk/Sty was determined
with a rabbit anti-myc antibody and fluorescein-conjugated sec-
ondary antibody. Images were taken from a 633 objective of a
Zeiss LSM 410 microscope and analyzed with a Kontron IBAS
confocal imaging system. Bar, 10 mm. 
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cap on 
 
b
 
-globin mRNA reduced its translation by fourfold
(Darzynkiewicz et al., 1988).
Expression of the Clk/Sty kinase in COS-1 cells causes
the release of the ASF/SF2 SR protein from the speckles
(Colwill et al., 1996). The dual specificity Clk/Sty kinase
phosphorylates the serine/arginine-rich region (RS do-
main) of SR splicing factors. Phosphorylation of this do-
main is required for the activation of SR splicing factors
(Mermoud et al., 1994) and has been implicated in protein–
protein interactions (Kohtz et al., 1994). Since Clk/Sty interacts
with ASF/SF2 through its RS domain, it may also associate
and phosphorylate other constituents of the speckles and
participate in a more general mechanism of splicing activa-
tion. Expression of Clk/Sty 
 
wt
 
, but not of Clk/Sty
 
K190R
 
, dis-
persed the nuclear eIF4E speckles. These results suggest
that the nuclear localization of eIF4E is dependent on the
distribution of SR splicing factors or, more generally, on
splicing activity. Since eIF4E does not contain an RS mo-
tif, the identification of nuclear eIF4E-binding proteins
should be helpful in establishing the mechanism by which
Clk/Sty releases eIF4E from the speckles.
Since our results raise the possibility that eIF4E is asso-
ciated with splicing factors, eIF4E could be involved in
splicing and/or mRNA export. There is persuasive evi-
dence that the nuclear CBC is important for mRNA splic-
ing (Izaurralde et al., 1994; Lewis et al., 1996) and Usn-
RNA export (Izaurralde et al., 1995). eIF4E perhaps could
be required for the processing of a specific subset of
mRNAs. eIF4E may be colocalized with splicing compo-
nents and regulated in a similar fashion to prevent its asso-
ciation with the monomethylated cap structure of snRNAs.
A subset of snRNAs, including U1, U2, U4, and U5, are
transcribed by RNA polymerase II and acquire a mono-
methylated cap structure before their export to the cyto-
plasm for hypermethylation (Huber et al., 1998). As these
snRNAs are not spliced, targeting of eIF4E to pre-mRNAs
through its interaction with specific splicing factors could
provide an effective way to prevent the tethering of snRNAs
to the translation machinery.
Previous studies showed that overexpression of eIF4E
in NIH3T3 cells increases cyclin D1 expression by stimu-
lating its mRNA export (Rousseau et al., 1996). However,
it is not known whether eIF4E stimulates cyclin D1
mRNA export directly through its association with the cap
in the nucleus, or indirectly by increasing the levels of a
protein involved in the export of this mRNA. Neverthe-
less, it seems reasonable that once associated with the cap,
eIF4E will accompany the RNA to the cytoplasm. Since
eIF4E is retained in rounded up speckles after transcrip-
tion inhibition and is colocalized with splicing factors, it
remains to be determined whether eIF4E binds to the
cap early during RNA polymerase II transcription, and
whether it could be involved in 3
 
9
 
 mRNA processing,
splicing, and nucleocytoplasmic transport of mRNA.
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